The World Hypertension League (WHL) Conducts Mega Awareness Programme in Partnership with IPCA Laboratories with more than 200 Doctors from various Hospitals and 300+ Patient to Create Record’s Initiative on Hypertension in Chennai

Chennai, June 2023: The World Hypertension League (WHL), conducting a mega hypertension awareness programme in partnership with IPCA Laboratories. Attempting in Asia Book of records and India’s book of records by making “LARGEST SENTENCE FOR CREATED FOR HYPERTENSION AWARENESS” in the Sentence of “MEASURE, CONTROL, LIVE LONGER” width would be 55ft and height is 12ft with using multi-coloured sticky notes in Chettinad Vidyashram, Chennai on 11th June’23 with more than 200 doctors from various hospitals and 300+ patient with hypertension Awareness Campaign.

The World Hypertension League (WHL) is a non-profit, non-governmental organization dedicated to the prevention and control of hypertension globally. Hypertension is a driving force in the global epidemic of non-communicable diseases (NCDs) and is the leading risk factor for death and disability globally. WHL membership is currently comprised of 80 national hypertension societies who are members of our Council and led by the WHL Executive, Board, Council, and Committees. WHL is a global organization with regional offices in North and South America, China, South East Asia, Sub Saharan Africa, the South Pacific, Eastern Europe and the Middle East.

Dr. S. N. Narasingan, Vice President, World Hypertension League, said Goal of Hypertension Awareness & Control in India World Hypertension League has partnered with Ipca Laboratories Ltd. in building an initiative to educate Indian masses about increasing risk of Hypertension leading many heart complications which can be fatal to life is ignored or left untreated.

As per World Health Organization report for South East Asia with focus on India mentions that its estimated that at least one in four adults in India has hypertension 1, but, only about 12% of them have their blood pressure under control 2
India has set a target of 25% relative reduction in the prevalence of hypertension (raised blood pressure) by 20253

Panel members Dr.Rajan Ravichandran, Senior Consultant Nephrologist, MIOT Hospital, Dr.P.Soundararajan, Senior Consultant Nephrologist, Apollo Hospital, Dr.D.Prabhakar, Consultant Interventional Cardiologist, Apollo Firstmed Hospital, Dr.S.S.Lakshmanan, MD, Priya Nursing Home, Dr.K.Shanmugam, Senior Consultant Physician, Stedford Hospital, Dr.Vijay Viswanathan, MD, M.V.Hospital, Dr.E.Prabhu, Prof.of Nuclear Medicine, Omanandurar Multi Speciality Hospital, Dr.K.Bhanu, Director of Neurology & Neurosurgery, Mehta Hospital & Dr.P.Paranthaman, Prof. of Medicine, Kilpauk Medical College are participated in the public interactive awareness on Hypertension.

For further details please contact:
Valarmathi – 90879 45221 / Dinesh – 81247 18171
Ethos Public Relations | Tel: 044 – 4356 2351 |

Previous post Tata Motors disrupts the CNG market with the launch of Altroz iCNG
Next post Employee Well-Being and Psychological Safety Key Concerns in the Workplace: Gi Group Holding India Research